期刊
MOLECULES
卷 24, 期 15, 页码 -出版社
MDPI
DOI: 10.3390/molecules24152739
关键词
iridium(III) complex; apoptosis; mitochondria; cancer
资金
- Hong Kong Baptist University [FRG2/17-18/003]
- Health and Medical Research Fund [HMRF/14150561]
- National Natural Science Foundation of China [21575121, 21775131, 21762018]
- Hong Kong Baptist University Century Club Sponsorship Scheme 2018
- Interdisciplinary Research Matching Scheme [RC-IRMS/16-17/03]
- Interdisciplinary Research Clusters Matching Scheme [RC-IRCs/17-18/03]
- Collaborative Research Fund [C5026-16G]
- SKLEBA
- HKBU Strategic Development Fund [SKLP_1718_P04]
- Science and Technology Development Fund, Macau SAR [0072/2018/A2]
- University of Macau [MYRG2016-00151-ICMS-QRCM, MYRG2018-00187-ICMS]
Targeting apoptosis is a principal strategy in the design of anticancer drugs. In recent years, non-platinum-based scaffolds have been exploited as viable candidates for the exploitation of anticancer agents with potentially lower toxicity than the widely used cisplatin analogues. This review highlights the latest advances in developing iridium(III) complexes as anticancer agents that act particularly via targeting apoptotic cell death in cancer cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据